Aker BioMarine ASA - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 4 PAGES: 22

Aker BioMarine ASA (Aker BioMarine) is a biotechnology company, based in Norway. The company manufactures, sells, and markets krill based products to animal, human nutrition, and pharmaceutical markets primarily in North and South America, European Union, Asia, and Norway. Its products include superba krill oil, superba krill caps, qrill, and CLA and tonalin. The company offers krill oil products for the human market under the brand name Superba. It also offers superba krill caps, a capsulated krill product; krill meal and krill oil products for aquaculture feed markets under the qrill brand; and conjugated linoleic acid, a fatty acid. The company has offices in the European Union, North America, Norway, and Asia. Aker BioMarine is headquartered in Oslo, Norway.

More Info
									          Aker BioMarine ASA - Pharmaceuticals & Healthcare - Deals and Alliances
                                        Profile
       Reference Code: GDPH81761D                                                                                                               Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      Aker BioMarine ASA (Aker BioMarine) is a biotechnology company, based in
                                                                                                              Aker BioMarine ASA, Pharmaceuticals &
      Norway. The company manufactures, sells, and markets krill based products to
                                                                                                              Healthcare, Key Facts
      animal, human nutrition, and pharmaceutical markets primarily in North and South
      America, European Union, Asia, and Norway. Its products include superba krill oil,                       Web Address                            www.akerbiomarine.co
      superba krill caps, qrill, and CLA and tonalin. The company offers krill oil products                                                           m
      for the human market under the brand name Superba. It also offers superba krill
                                                                                                               Revenue (US$ million)                                 NA
      caps, a capsulated krill product; krill meal and krill oil products for aquaculture feed
      markets under the qrill brand; and conjugated linoleic acid, a fatty acid.                               Number of Employees                                   NA
                                                                                                               GlobalData

      Financial Deals Landscape
        Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals by                        Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                 2                          2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                                                                           1          1
                                                                                                          1


                                                                                                                           0       0                  0
                                                                                                          0
                                                                                                               2007       2008   2009      2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals                          Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013

                         8
                               6
          No. of Deals




                                                                                           No. of Deals




                                                                                                          1
                         6                                                                                            1
                         4

                         2              1
                                                 0         0         0
                         0                                                                                                             0          0              0
                             Europe   Middle    Asia-    North    South                                   0
                                       East    Pacific   Americ    and                                           Central         Cardiova Metabolic       Pharmac
                                       and                 a      Central                                        Nervous          scular  Disorder         euticals
                                      Africa                      Americ                                         System                       s              and
                                                                    a                                                                                     Healthcar
                                                                                                                                                              e


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




Aker BioMarine ASA - Pharmaceuticals & Healthcare - Deals and                                                                                     Reference Code: GDPH81761D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................. 4
       Aker BioMarine ASA, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................. 5
       Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................. 6
       Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................... 7
       Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 .............................................................. 8
       Aker BioMarine ASA, Pharmaceuticals & Healthcare, Deal Details ................................................................................................... 9
          Private Equity.................................................................................................................................................................................. 9
             Lindsay Goldberg Acquires Minority Stake In Trygg Pharma Holding ......................................................................................... 9
          Partnerships.................................................................................................................................................................................. 11
             Aker BioMarine Enters Into Co-Development Agreement With Lipogen ................................................................................... 11
          Merger .......................................................................................................................................................................................... 12
             Aker BioMarine ASA Merges With Natural ASA ........................................................................................................................ 12
          Equity Offering .............................................................................................................................................................................. 13
             Aker BioMarine Completes Rights Offering Of Common Stock For $18 Million ........................................................................ 13
             Aker BioMarine Completes Rights Offering Of Common Stock For $43.5 Million ..................................................................... 14
          Debt Offering ................................................................................................................................................................................ 15
             Aker BioMarine ASA Completes Bonds Issue ........................................................................................................................... 15
       Aker BioMarine ASA - Key Competitors ........................................................................................................................................... 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
       R
								
To top